ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up

Friedemann Honecker; Jorge Aparicio; Daniel M. Berney; J. Beyer; Carsten Bokemeyer; Richard Cathomas; Noel W. Clarke; Gabriella Cohn‐Cedermark; Gedske Daugaard; K.-P. Dieckmann; Karim Fizazi; Sophie D. Fosså; J. R. Germa-Lluch; Patrizia Giannatempo; Jourik A. Gietema; Silke Gillessen; Hege Sagstuen Haugnes; Axel Heidenreich; Kari Hemminki; Robert Huddart; Michael A.S. Jewett; Florence Joly; Jakob Lauritsen; Anja Lorch; Andrea Necchi; Nicola Nicolai; Christoph Oing; Jan Oldenburg; D Ondruš; Alexandros Papachristofilou; Thomas Powles; Aslam Sohaib; O. Ståhl; Torgrim Tandstad; Guy C. Toner; A. Horwich

doi:10.1093/annonc/mdy217

ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up

Friedemann Honecker(Universität Hamburg), Jorge Aparicio(Hospital Universitari i Politècnic La Fe), Daniel M. Berney(Queen Mary University of London), J. Beyer(University of Bern), Carsten Bokemeyer(Universität Hamburg), Richard Cathomas(Kantonsspital Graubünden), Noel W. Clarke(The Christie NHS Foundation Trust), Gabriella Cohn‐Cedermark(Karolinska University Hospital), Gedske Daugaard(Copenhagen University Hospital), K.-P. Dieckmann(Asklepios Klinik Altona), Karim Fizazi(Université Paris-Sud), Sophie D. Fosså(Oslo University Hospital), J. R. Germa-Lluch(Institut Català d'Ornitologia), Patrizia Giannatempo(Fondazione IRCCS Istituto Nazionale dei Tumori), Jourik A. Gietema(University Medical Center Groningen), Silke Gillessen(University of Bern), Hege Sagstuen Haugnes(University Hospital of North Norway), Axel Heidenreich(University of Cologne), Kari Hemminki(German Cancer Research Center), Robert Huddart(Institute of Cancer Research), Michael A.S. Jewett(University Health Network), Florence Joly(Centre François Baclesse), Jakob Lauritsen(Copenhagen University Hospital), Anja Lorch(Düsseldorf University Hospital), Andrea Necchi(Fondazione IRCCS Istituto Nazionale dei Tumori), Nicola Nicolai(Fondazione IRCCS Istituto Nazionale dei Tumori), Christoph Oing(Universität Hamburg), Jan Oldenburg(Akershus University Hospital), D Ondruš(Cancer Institute (WIA)), Alexandros Papachristofilou(University Hospital of Basel), Thomas Powles(Queen Mary University of London), Aslam Sohaib(Royal Marsden Hospital), O. Ståhl(Lund University), Torgrim Tandstad(St Olav's University Hospital), Guy C. Toner(The University of Melbourne), A. Horwich(Institute of Cancer Research)

Annals of Oncology

June 18, 2018

10.1093/annonc/mdy217

Cited by 326Open Access

Full Text

Abstract

Related Papers

TNM Classification of Malignant Tumours

|Unknown|1987|16.1k

Cancer Incidence in Five Continents

Richard Doll, C. S. Muir, John A. H. Waterhouse|Unknown|1970|8.5k

International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group.

|Journal of Clinical Oncology|1997|1.9k

Guidelines on Testicular Cancer: 2015 Update

Peter Albers, Walter Albrecht, Ferrán Algaba et al.|European Urology|2015|673

Prognostic Factors in Patients With Metastatic Germ Cell Tumors Who Experienced Treatment Failure With Cisplatin-Based First-Line Chemotherapy

The International Prognostic Factors Study Group|Journal of Clinical Oncology|2010|315